Immunohistochemistry revealed MMP-2 positivity in 38% of glioma cases and MMP-9 positivity in 81%, with MMP-9 also observed in endothelial cells, suggesting its role in angiogenesis. The gene discussed is MMP2; the disease is central nervous system cancer.